Switch to:
Bio-Reference Laboratories Inc (NAS:BRLI)
Cash Flow for Capital Expenditures
$-24.2 Mil (TTM As of Apr. 2015)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bio-Reference Laboratories Inc's cash flow for capital expenditures for the three months ended in Apr. 2015 was $-11.6 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Apr. 2015 was $-24.2 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bio-Reference Laboratories Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Apr. 2015 was -4.018 (Jul. 2014 ) + -4.457 (Oct. 2014 ) + -4.149 (Jan. 2015 ) + -11.59 (Apr. 2015 ) = $-24.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Bio-Reference Laboratories Inc Annual Data

Oct05Oct06Oct07Oct08Oct09Oct10Oct11Oct12Oct13Oct14
Cash Flow_CPEX -2.9-2.9-7.8-8.0-8.9-16.5-14.1-15.7-25.1-15.5

Bio-Reference Laboratories Inc Quarterly Data

Jan13Apr13Jul13Oct13Jan14Apr14Jul14Oct14Jan15Apr15
Cash Flow_CPEX -4.8-5.8-7.0-7.5-2.8-4.3-4.0-4.5-4.1-11.6
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK